Evaluation of the TruSight Tumor 170 Assay and Its Value in Clinical Diagnostics
Background: Parallel sequencing technologies have become integrated into clinical practice. This study evaluated the TruSight Tumor 170 assay for the simultaneous detection of somatic gene mutations (SNPs and indels), gene fusions and CNVs, and its implementation into routine diagnostics. Methods: F...
Spremljeno u:
| Glavni autori: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2022-02-01
|
| Serija: | Journal of Molecular Pathology |
| Teme: | |
| Online pristup: | https://www.mdpi.com/2673-5261/3/1/6 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|